Paul Hampel, Kari Rabe, Matthew Maurer, Yucai Wang, Saad Kenderian, Eli Muchtar, Lindsey Roeker, Jose Leis, Mazie Tsang, Talal Hilal, Ricardo Parrondo, Amber Koehler, Rachel Bailen, Catherine Coddington, Amy Behnken, Susan Schwager, Curtis Hanson, Esteban Braggio, Min Shi, Cinthya Mendoza, Susan Slager, Neil Kay, Sameer Parikh. "Progression of disease within 36 months (POD36) of starting first-line targeted therapy independently predicts poor overall survival in patients with chronic lymphocytic leukemia (CLL)." Blood, 2025. doi:10.1182/blood-2025-5667